| Financial Year |
March 31 2023 |
| Monetary Funds |
4,454,401,994.49 |
| Held-for-trading Financial Assets |
584,737,464.25 |
| Notes Receivable |
177,105,525.36 |
| Accounts Receivable |
3,568,416,438.66 |
| Advances to Suppliers |
260,367,240.71 |
| Other Receivables |
321,009,941.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
4,000,000.00 |
| Inventories |
1,899,652,778.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,818,094.53 |
| Other Current Assets |
3,254,107,898.58 |
| Total Current Assets |
15,069,352,404.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
232,935,753.47 |
| Long-term Equity Investment |
5,410,424,464.69 |
| Investment Properties |
221,616,124.47 |
| Fixed Assetes |
23,820,525,737.72 |
| Under-construction Projects |
6,201,328,034.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,260,020,871.08 |
| R&D expenses |
-- |
| Goodwill |
1,475,612,178.54 |
| Long-Term Deferred and Prepaid Expenses |
85,957,831.15 |
| Deferred Income Tax Assets |
925,939,504.68 |
| Other Non-Current Assets |
1,993,627,215.35 |
| Sub-Total of Non-Current Assets |
49,290,180,943.17 |
| Total Assets |
64,359,533,348.12 |
| Short-Term Loans |
3,005,018,200.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,885,929,330.30 |
| Accounts Payable |
4,551,193,714.15 |
| Accounts Received In Advance |
403,082.18 |
| Employee Compensation Payable |
282,607,585.08 |
| Taxes Payable |
223,077,185.78 |
| Interest Payable |
-- |
| Dividend Payable |
16,469,385.18 |
| Other payables |
625,636,057.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,779,640,345.54 |
| Other Current Liabilities |
252,676,721.52 |
| Sub-Total of Current Liabilities |
15,541,862,967.29 |
| Long-term Loans |
12,370,908,679.84 |
| Bonds Payable |
6,380,000,000.00 |
| Long-Term Accounts Payable |
5,295,529.47 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
629,796,333.10 |
| Other Non-Current Liabilities |
201,113,491.04 |
| Sub-Total of Non-Current Liabilities |
21,851,308,411.44 |
| Total Liabilities |
37,393,171,378.73 |
| Paid-In Capital(Or Share Stock) |
3,544,055,525.00 |
| Capital Surplus |
9,072,912,728.41 |
| Surplus Reserve |
2,921,804,982.16 |
| LESS:Treasury Stock |
230,618,697.88 |
| Undistributed Profits |
8,472,453,872.26 |
| Minority Stockholder's Interest |
2,291,662,404.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
24,674,699,565.35 |
| Owner's Equity（Stockholder's Equity） |
26,966,361,969.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
64,359,533,348.12 |
